Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies

Journal of Neuroimaging

Volumn 18, Issue 2, 2008, Pages 137-141

  Xuan, Xiaqing ^a   Ding, Meiping ^a   Gong, Xiangyang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diffuse Lewy body disease; N acetylaspartate; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NEUROCHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE;

AGED; ASPARTIC ACID; CHI-SQUARE DISTRIBUTION; CHOLINE; CREATINE; DEMENTIA; FEMALE; HIPPOCAMPUS; HUMANS; LEWY BODY DISEASE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS;

EID: 41549146867     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00203.x     Document Type: Article

References (39)

1. Mckeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox J, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996 47 (5 1113 1124.
2. Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, Mckeith IG. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 1994 5 : 747 749.
3. Mega MS, Masterman DL, Benson F, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings JL. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996 47 : 1403 1409.
4. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999 174 : 45 51.
5. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 : 189 198.
6. Hughes CP, Berg I, Danziger WL, et al. A new clinical state for the staging of dementia. Br J Psychol 1982 140 : 566 572.
7. Stemmler M, Steinwacbs KC, Lebfeld H, et al. Different methodological approaches for the construction of a therapy sensitive ADL scale for the assessment of Alzheimer patients. New Trends in the Diagnosis and Therapy of Alzheimer's Disease. Spinnger-Verlag Wien New York 1994 : 81 89.
8. Wechsler D. WISC-R Manual Wechsler Intelligence Scale for the Children-Revised. New York : Psychological Corporation, 1974.
9. Butters N, Granholm E, Salmon DP, et al. Episodic and semantic memory: A comparison of amnesic and demented patients. J Clin Exp Neuropsychol 1987 9 : 479 497.
10. Molina JA, Garcia-Segura JM, Benito-Leon J, Gomez-Escalonilla C, del Ser T, Martinez V, Viano J. Proton magnetic resonance spectroscopy in dementia with Lewy bodies. Eur-Neurology 2002 48 (3 158 163.
11. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wei DF, O'Brein PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangolas EG, Jack CR Jr. 1H-MR spectroscopy in common dementias. Neurology 2004 63 : 1393 1398.
12. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 2001 82 : 239 259.
13. Kwo-On-Yuen PF, Newmark RD, Budinger TF, Kaye JA, Ball MJ, Jagust WJ. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Res 1994 26 (667 167 174.
14. Mohanakrishnan P, Fowler AH, Vonsattel JP, Jolles PR, Husain MM, Liem P, Myers L, Komoroski RA. Regional metabolic alterations in Alzheimer's disease: an in vitro 1H-NMR study of the hippocampus and cerebellum. J Gerontol A Biol Sci Med Sci 1997 52 : B111 B117.
15. Passani LA, Vonsattel JP, Carter RE, Coyle JT. N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases. Mol Chem Neuropathol 1997 31 : 7 118.
16. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994 32 : 110 115.
17. Jessen F, Block W, Traber F, Keller E, Flacke S, Lamerichs R, Schild HH, Heun R. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 2001 57 (5 930 932.
18. Jessen F, Block W, Traber F, Keller E, Flacke S, Papassotiropoulos A, Lamerichs R, Heun R, Schild HH. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 2000 55 (5 684 688.
19. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JG. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000 47 : 718 728.
20. Lippa CF, Johnson R, Smith TW. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease. Ann Neurol 1998 43 : 102 106.
21. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998 51 : 357 362.
22. Harvey GT, Hughes J, McKeith IG, Briel R, Ballard C, Gholkar A, Scheltens P, Perry RH, Ince P, O'Brien JT. Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study. Psychol Med 1999 29 : 181 187.
23. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 1997 49 : 1513 1521.
24. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry 1999 56 : 185 192.
25. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001 56 : 592 598.
26. Tsai G, Coyle JT. N-Acetylaspartate in neuropsychiatric disorders. Progr Neurobiol 1995 46 : 531 540.
27. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, Bruck W. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999 20 : 1619 1627.
28. Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994 36 : 40 47.
29. Heun R, Schlegel S, Graf-Morgenstern M, Tintera J, Gawehn J, Stoeter P. Proton magnetic resonance spectroscopy in dementia of Alzheimer type. Int J Geriatr Psychiatry 1997 12 : 349 358.
30. MacKay S, Ezekiel F, Sclafani VD, Meyerhoff DJ, Gerson J, Norman D, Fein G, Weiner MW. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996 198 : 537 545.
31. Christiansen P, Schlosser A, Henriksen O. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995 13 : 457 462.
32. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994 117 : 49 58.
33. Kamada K, Houkin K, Iwasaki Y, Abe H, Kashiwaba T. In vivo proton magnetic resonance spectroscopy for metabolic changes of human brain edema. Neurol Med Chir (Tokyo) 1994 34 : 676 681.
34. Brooks WM, Stidley CA, Petropoulos H, Jung RE, Weers DC, Friedman SD, Barlow MA, Sibbitt WL Jr., Yeo RA. Metabolic and cognitive response to human traumatic brain injury. J Neurotrauma 2000 17 : 629 640.
35. Hugg JA, Kuzniecky RI, Gilliam FG, Morawetz RB, Fraught RE, Hetheington HP. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996 40 : 236 239.
36. Meyerhoff DJ, Mackay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994 36 : 40 47.
37. Heun R, Schlegel S, Graf-morgenstern M, Tintera J, Gawehn J, Stoeter P. Proton magnetic resonance spectroscopy in dementia of Alzheimer type. Int J Geriatr Psychiatry 1997 12 : 349 358.
38. Mackay S, Ezekiel F, Sclafani VD, Meyerhoff DJ, Gerson J, Norman D, Fein G, Weiner MW. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996 198 : 537 545.
39. Christiansen P, Schlosser A, Henriksen O. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995 13 : 457 462.